The CATIE schizophrenia effectiveness trial

Schizophr Res. 2005 Dec 1;80(1):v-vi. doi: 10.1016/j.schres.2005.10.004.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / therapeutic use
  • Clinical Trials as Topic
  • Dibenzothiazepines / administration & dosage
  • Dibenzothiazepines / therapeutic use*
  • Drug Administration Schedule
  • Drug Tolerance
  • Humans
  • Olanzapine
  • Perphenazine / administration & dosage
  • Perphenazine / therapeutic use*
  • Quetiapine Fumarate
  • Risperidone / administration & dosage
  • Risperidone / therapeutic use*
  • Schizophrenia / drug therapy*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Benzodiazepines
  • Quetiapine Fumarate
  • Perphenazine
  • Risperidone
  • Olanzapine